About this document

Botulinum A Toxin for Blepharospasm Treatment by Herelinu is a document available to read on EtoBox.

This study evaluated the efficacy and safety of botulinum A toxin injections for treating blepharospasm in 39 patients, with results showing significant symptom relief lasting up to 170 days. The treatment was found to be dose-dependent, with complications such as tearing and ptosis occurring in some cases, particularly in patients with prior eyelid surgeries. Overall, the injections were deemed safe and effective, leading to a recommendation for a dosage adjustment based on the duration of symptom relief e

Author

Herelinu

Language

EN